Industry / United States
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
FDA To Strengthen Abacavir Warning
July 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
According to the New York Times, the US Food and Drug Administration (FDA) is expected to release an advisory recommending that doctors conduct a genetic test on patients with HIV/AIDS before prescribing abacavir in order to prevent severe allergic reaction to the drug.